Beginning Cash: The amount of cash reported by the company on its previous statement.
AC Immune (ACIU) had Beginning Cash of $35.18M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$16.49M |
|
$-60.41M |
|
-- |
|
$16.49M |
|
$76.22M |
|
$-59.73M |
|
$-0.67M |
|
$-60.40M |
|
$-60.40M |
|
$-60.41M |
|
$-60.41M |
|
$-60.41M |
|
$-60.41M |
|
$-59.73M |
|
$-57.26M |
|
84.69M |
|
84.69M |
|
$-0.71 |
|
$-0.71 |
|
Balance Sheet Financials | |
$139.41M |
|
$3.76M |
|
$64.23M |
|
$203.64M |
|
$15.12M |
|
-- |
|
$9.57M |
|
$24.70M |
|
$178.94M |
|
$122.78M |
|
$178.94M |
|
99.20M |
|
Cash Flow Statement Financials | |
$-67.29M |
|
$73.12M |
|
$48.18M |
|
Beginning Cash |
$35.18M |
$87.43M |
|
$52.25M |
|
$4.86M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
9.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-362.30% |
|
-362.30% |
|
-347.33% |
|
-366.35% |
|
-366.41% |
|
$-68.18M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
0.96 |
|
380.31 |
|
-33.76% |
|
-49.20% |
|
-29.67% |
|
-33.76% |
|
$1.80 |
|
$-0.81 |
|
$-0.79 |